High class I HDAC activity and expression are associated with RelA/p65 activation in pancreatic cancer <it>in vitro </it>and <it>in vivo</it>

High class I HDAC activity and expression are associated with RelA/p65 activation in pancreatic cancer <it>in vitro </it>and <it>in vivo</it>

<p>Abstract</p> <p>Background</p> <p>The strong association between aberrant HDAC activity and the occurrence of cancer has led to the development of a variety of HDAC inhibitors (HDIs), which emerge as promising new targeted anticancer therapeutics.</p> <p>...

Full description

Bibliographic Details
Main Authors: Neuhaus Peter, Bahra Marcus, Müller Berit, Noske Aurelia, Darb-Esfahani Silvia, Buckendahl Ann-Christin, Budczies Jan, Denkert Carsten, Lehmann Annika, Dietel Manfred, Kristiansen Glen, Weichert Wilko
Format: Article
Language:English
Published: BMC 2009-11-01
Series:BMC Cancer
Online Access:http://www.biomedcentral.com/1471-2407/9/395

Internet

http://www.biomedcentral.com/1471-2407/9/395

Similar Items